Compounding Oversight May Hinge On How FDA Treats Office Stock

 

By Derrick Gingery / Email the Author / View Full Issue
Regulatory Update / Word Count: 1147 / Article # 00140210002 / Posted: February 10 2014 12:01 AM

---

Executive Summary

Pew asks FDA to look at large-scale compounders of office stocks and help encourage them to register, but IACP argues regulation of the office stock should remain with the states.

---

Purchase this Article

$50.00   Buy Now